Latest News - Abbott Laboratories
Top Corporates Hub
Abbott Laboratories
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
26.08.2026 09:36
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.
Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles
26.08.2026 08:22
Discover why Abbott Labs (ABT) clears a quality screen with high ROIC, solid growth, and 96.8% profit quality. Valuation below market adds appeal.
10 Health Care Stocks Whale Activity In Today’s Session
25.08.2026 13:35
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term
19.08.2026 07:15
Abbott stays a buy after Q2 beat/raise; Exact Sciences boosts growth. Click for more on ABT stock.
Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?
10.08.2026 14:43
Abbott's Medical Devices growth, EPD momentum and improving Nutrition support its outlook, but China risks, costs and valuation warrant caution.
Here's How ABT Broadens Diagnostics Growth Base With Oncology Expansion
07.08.2026 14:49
Abbott broadens Diagnostics growth with Exact Sciences, as Cancer Diagnostics gains and resilient routine testing offset respiratory weakness.
What Makes Abbott Laboratories (ABT) a Compelling Investment Opportunity with Reliable Growth
07.08.2026 12:37
Matrix Asset Advisors, an asset management company, released its Q2 2026 investor letter. A copy of the letter can be downloaded here. The stock market rebounded strongly in the second quarter, with the S&P 500 gaining 15.2% in the quarter and 10.2% year-to-date. Investors overlooked inflation concerns exceeding 4% and geopolitical tensions, focusing instead on […]
Abbott (ABT) Stock Looks Like A Bargain Below Fair Value
02.08.2026 17:14
Abbott Laboratories stock has fallen about 15% over the past year, yet a Discounted Cash Flow (DCF) intrinsic value estimate still points to meaningful upside compared with where the shares currently trade. At the same time, the broader valuation checks and market multiples suggest a picture that is closer to fair than clearly cheap. Over the past 12 months, Abbott Laboratories shares are down about 15%, which raises the question of whether recent weakness has already priced in key...
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
31.07.2026 19:49
Abbott trades at a cheaper valuation but carries higher litigation risk, while J&J boasts superior profitability despite a pending talc settlement.
Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook
31.07.2026 14:42
Guardant Health is Thursday's IBD Stock Of The Day in a thriving market for colon cancer screening tests. On Friday, Guardant Health stock surged after the company raised full-year outlook after a Q2 revenue beat late Thursday. Several analysts raised price targets on GH stock after the Q2 report, by as much as $50 a share, according to TheFly.com.
Abbott Laboratories (NYSE:ABT): A Strong Candidate for Quality Investors
30.07.2026 08:30
Abbott Laboratories (ABT) meets quality investing criteria with strong 8.42% revenue growth, 19.34% ROIC, and near-perfect cash conversion, making it a compelling candidate for long-term investors.
Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends
28.07.2026 13:29
ABT is expanding across diabetes care, oncology diagnostics and heart devices, with new launches and acquisitions creating multiple growth paths to watch.
Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance
28.07.2026 11:45
Cloud-based AI algorithm supports implantable cardiac monitors from all major manufacturers, reducing false-positive alerts by up to 76% while maintaining high sensitivity for true events CAMBRIDGE, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation ILR ECG Analyzer, marking Implicity's third FDA cleara
Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher
24.07.2026 15:15
Companies raising guidance, particularly on the earnings front, always deserve some level of attention from investors. Recently, JNJ, GM, and ABT have all raised their outlooks.
6 Medical-Device Stocks to Buy After a Massive Selloff
24.07.2026 12:25
Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.
Medical-Device Stocks Are in the Bargain Bin. 6 to Buy.
24.07.2026 05:30
Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.
Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value?
23.07.2026 01:10
Abbott Laboratories earnings put recent stock moves in context Abbott Laboratories (ABT) is back in focus after its latest quarterly earnings, where higher year over year sales came alongside lower net income and earnings per share, sharpening attention on upcoming estimates. See our latest analysis for Abbott Laboratories. After these earnings, Abbott Laboratories' recent rally stands out, with a 7 day share price return of 12.66% and a 30 day share price return of 14.51% contrasting with a...
Unusual volume S&P500 stocks in Thursday's session
16.07.2026 17:05
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Exploring the top movers within the S&P500 index during today's session.
16.07.2026 16:35
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.